LESSENGERS Demonstrates 800G QSFP-DD and 400G QSFP112 Optical Transceivers
12.9.2022 13:00:00 EEST | Business Wire | Press release
LESSENGERS Inc. (“LESSENGERS”), an innovative optical interconnect solution provider, announced today, a live demonstration of polymer-wired 800G QSFP-DD and 400G QSFP112 optical transceivers without the use of any lens optics, providing excellent performance and cost-effectiveness, during the ECOC 2022 (Stand 511 and MR31), the largest optical communications exhibition in Europe, on September 19 – 21, at Messe Basel, Switzerland.
Powered by LESSENGERS’s patent direct optical wiring (DOW) technology, the LESSENGERS 800G QSFP-DD and 400G QSFP112 optical transceivers achieve excellent optical signal integrity and best cost-effectiveness. This unique technology enables complete passive alignment with high-precision and -density optical coupling without the use of lens optics, providing the most suitable solutions for high-speed data center applications such as 800G/1.6T optical modules, on-board, near packaged or co-packaged optics.
“LESSENGERS will demonstrate a set of 112G and 56G signaling-based products during the show, ECOC 2022 on September 19 – 21 to support our customers in urgent needs and will be adding products in the upcoming quarters to complete its product portfolio,” said Taeyong Kim, CMO at LESSENGERS.
“LESSENGERS’s current business is focused on multimode-based optical interconnect solutions along with customized optical packaging services, however, we will continue to push forward on single-mode-based applications such as silicon photonics,” added Chongcook Kim, CEO at LESSENGERS. “This successful demonstration of DOW technology-based optical transceiver solutions will bring a new era of data center optical interconnects and the development of these technologies will support future requirements for high performance computing (HPC) and artificial intelligence (AI) solutions.
LESSENGERS’s demonstration will be with:
- 800G QSFP-DD SR8 optical transceiver
- 400G QSFP112 SR4 optical transceiver
- 200G QSFP56 SR4 optical transceiver
- 200G ultra-small sized optical module
About LESSENGERS
LESSENGERS Inc. is an innovative optical interconnect solution provider. Its patent direct optical wiring (DOW) technology enables high-precision and high-density submicrometer scale optical coupling between high-speed photonic devices and various optical waveguides with the best cost-effectiveness. LESSENGERS’s 800G/400G/200G optical transceiver/active optical cable solutions are powered by the high-performance manufacturing-oriented DOW technologies.
Please visit www.lessengers.com for more information.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220912005022/en/
Contact information
LESSENGERS Inc.
Taeyong Kim, Ph.D
Chief Marketing Officer
+82-10-6549-7654
taeyong.kim@lessengers.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
High-end Aesthetic Brand ‘Lorient’ Gains Global Prestige at IMCAS 20261.2.2026 09:00:00 EET | Press release
Lorient, a premium aesthetic brand, announced that it has drawn global attention at the 27th IMCAS World Congress 2026 in Paris, attracting over 15,000 professionals and demonstrating its leadership in aesthetic innovation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131322203/en/ Lorient’s low degree of modification delivers a smooth injection experience and high biocompatibility (Image: Lorient) The highlight was a session led by Dr. Jani van Loghem, a globally revered key opinion leader known for establishing international aesthetic safety protocols. His involvement provided a prestigious validation of the technical excellence of Lorient. Alongside him, prominent Korean medical experts Dr. Won Lee and Dr. Do Young Rhee shared clinical insights that drew widespread praise from the international medical community. Central to the academic discussions was Lorient’s "safety-first" philosophy for its premium HA filler ran
Sharjah Ruler Receives Portugal’s Grand Collar of Order of Camões31.1.2026 19:27:00 EET | Press release
His Excellency Marcelo Rebelo de Sousa, President of the Portuguese Republic, awarded His Highness Sheikh Dr Sultan bin Mohammed Al Qasimi, Supreme Council Member and Ruler of Sharjah, the Grand Collar of the Order of Camões (Grande Colar da Ordem de Camões), the highest sovereign cultural order in Portugal. His Highness is the first Arab figure to receive the Order of Camões and the sixth recipient worldwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260131119526/en/ Sharjah Ruler receives Portugal’s Grand Collar of Order of Camões (Photo: AETOSWire) The honour was conferred during a ceremony hosted by the Portuguese President at the Presidential Palace in Lisbon. The event was attended by Sheikha Bodour bint Sultan Al Qasimi, Chairperson of the Sharjah Book Authority, alongside senior officials. The ceremony recognised His Highness’s prominent global stature, as a leading figure in culture, intellectual thought and in
Incyte Announces Positive CHMP Opinion for Zynyz ® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 16:29:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “Today’s positive CHMP opinion is an important step towards addressing the urgent need for new treatment options for patients in Europe with advanced SCAC, a disease which has seen limited innovation for decades,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved, Zynyz in combination with platinum-based chemotherapy has the potential to become a new standard-of-care for patients living with this rare and difficult-to-treat cancer.” The positive CHMP opinion was based on data from the Phase 3 POD1UM-303/Inter
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 14:32:00 EET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 10:00:00 EET | Press release
With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerful, secure, reliable, and intelligent digital signage,” said Steve Durkee, chief executive office
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom